School of medicine, China Medical University, Taichung, Taiwan.
Department of Surgery, China Medical University Hospital, Taichung, Taiwan.
PLoS One. 2022 Aug 4;17(8):e0272068. doi: 10.1371/journal.pone.0272068. eCollection 2022.
The risk of peripheral artery occlusive disease (PAOD) in patients with lower leg fracture who underwent fixation procedures is not yet completely understood. Therefore, the current study aimed to examine the risk of subsequent PAOD in patients with lower leg fracture who received fixation and non-fixation treatments.
We included 6538 patients with lower leg fracture who received non-fixation treatment and a matched cohort comprising 26152 patients who received fixation treatment from the National Health Insurance Database. Patients were frequency matched according to age, sex, and index year. The incidence and risk of PAOD in patients with lower leg fracture who received fixation and non-fixation treatments were evaluated via the stratification of different characteristics and comorbidities.
Non-fixation treatment, male sex, older age (≥ 50 years old), diabetes mellitus, and gout were associated with a significantly higher risk of lower extremity PAOD compare to each comparison group, respectively. Moreover, there was a significant correlation between fixation treatment and a lower risk of lower extremity PAOD in women (adjusted hazard ratio [aHR] = 0.58, 95% confidence interval [CI] = 0.38-0.90), women aged > 50 years (aHR = 0.61, 95% CI = 0.38-0.96), and patients with coronary artery disease (aHR = 0.43, 95% CI = (0.23-0.81). Further, patients with fixation treatment had a significantly lower risk of lower extremity PAOD within 2 years after trauma (aHR = 0.57, 95% CI = 0.34-0.97). The Kaplan-Meier analysis showed that the cumulative incidence of PAOD was significantly higher in the non-fixation treatment group than in the fixation treatment group at the end of the 10-year follow-up period (log-rank test: P = 0.022).
Patients with lower leg fracture who received non-fixation treatment had a significantly higher risk of PAOD than those who received fixation treatment. Moreover, the risk of PAOD was higher in women aged > 50 years, as well as in coronary artery disease patients who received non-fixation treatment than in those who received fixation treatment. Therefore, regular assessment of vessel patency are recommended for these patients. Nevertheless, further studies must be conducted to validate the results of our study.
下肢骨折患者接受固定治疗后发生外周动脉闭塞性疾病(PAOD)的风险尚不完全清楚。因此,本研究旨在检查接受固定和非固定治疗的下肢骨折患者随后发生 PAOD 的风险。
我们纳入了 6538 名接受非固定治疗的下肢骨折患者和一个匹配队列,其中包括 26152 名接受固定治疗的患者,这些患者均来自国民健康保险数据库。根据年龄、性别和索引年度对患者进行频率匹配。通过对不同特征和合并症的分层,评估接受固定和非固定治疗的下肢骨折患者的 PAOD 发生率和风险。
与每个对照组相比,非固定治疗、男性、年龄较大(≥50 岁)、糖尿病和痛风与下肢 PAOD 的风险显著增加相关。此外,在女性(调整后的危险比[aHR] = 0.58,95%置信区间[CI] = 0.38-0.90)、年龄大于 50 岁的女性(aHR = 0.61,95% CI = 0.38-0.96)和患有冠心病的患者中,固定治疗与较低的下肢 PAOD 风险显著相关(aHR = 0.43,95% CI =(0.23-0.81)。此外,在创伤后 2 年内,接受固定治疗的患者下肢 PAOD 的风险显著降低(aHR = 0.57,95% CI = 0.34-0.97)。Kaplan-Meier 分析显示,在 10 年随访结束时,非固定治疗组的 PAOD 累积发生率明显高于固定治疗组(对数秩检验:P = 0.022)。
接受非固定治疗的下肢骨折患者发生 PAOD 的风险明显高于接受固定治疗的患者。此外,年龄大于 50 岁的女性以及接受非固定治疗的冠心病患者发生 PAOD 的风险高于接受固定治疗的患者。因此,建议对这些患者定期评估血管通畅情况。然而,还需要进一步的研究来验证我们研究的结果。